Copyright Reports & Markets. All rights reserved.

Global Phage Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Phage Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral
      • 1.4.3 External Application
      • 1.4.4 Surgical Treatment
    • 1.5 Market by Application
      • 1.5.1 Global Phage Therapy Market Share by Application (2014-2025)
      • 1.5.2 Human Medicine
      • 1.5.3 Veterinary Science
      • 1.5.4 Agriculture
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Phage Therapy Market Size
    • 2.2 Phage Therapy Growth Trends by Regions
      • 2.2.1 Phage Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Phage Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Phage Therapy Market Size by Manufacturers
      • 3.1.1 Global Phage Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Phage Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Phage Therapy Key Players Head office and Area Served
    • 3.3 Key Players Phage Therapy Product/Solution/Service
    • 3.4 Date of Enter into Phage Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Phage Therapy Market Size by Type (2014-2019)
    • 4.2 Global Phage Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Phage Therapy Market Size (2014-2019)
    • 5.2 Phage Therapy Key Players in United States
    • 5.3 United States Phage Therapy Market Size by Type
    • 5.4 United States Phage Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Phage Therapy Market Size (2014-2019)
    • 6.2 Phage Therapy Key Players in Europe
    • 6.3 Europe Phage Therapy Market Size by Type
    • 6.4 Europe Phage Therapy Market Size by Application

    7 China

    • 7.1 China Phage Therapy Market Size (2014-2019)
    • 7.2 Phage Therapy Key Players in China
    • 7.3 China Phage Therapy Market Size by Type
    • 7.4 China Phage Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Phage Therapy Market Size (2014-2019)
    • 8.2 Phage Therapy Key Players in Japan
    • 8.3 Japan Phage Therapy Market Size by Type
    • 8.4 Japan Phage Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Phage Therapy Market Size (2014-2019)
    • 9.2 Phage Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Phage Therapy Market Size by Type
    • 9.4 Southeast Asia Phage Therapy Market Size by Application

    10 India

    • 10.1 India Phage Therapy Market Size (2014-2019)
    • 10.2 Phage Therapy Key Players in India
    • 10.3 India Phage Therapy Market Size by Type
    • 10.4 India Phage Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Phage Therapy Market Size (2014-2019)
    • 11.2 Phage Therapy Key Players in Central & South America
    • 11.3 Central & South America Phage Therapy Market Size by Type
    • 11.4 Central & South America Phage Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Phage International
      • 12.1.1 Phage International Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Phage Therapy Introduction
      • 12.1.4 Phage International Revenue in Phage Therapy Business (2014-2019)
      • 12.1.5 Phage International Recent Development
    • 12.2 Adaptive Phage Therapeutics
      • 12.2.1 Adaptive Phage Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Phage Therapy Introduction
      • 12.2.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2014-2019)
      • 12.2.5 Adaptive Phage Therapeutics Recent Development
    • 12.3 AmpliPhi Biosciences
      • 12.3.1 AmpliPhi Biosciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Phage Therapy Introduction
      • 12.3.4 AmpliPhi Biosciences Revenue in Phage Therapy Business (2014-2019)
      • 12.3.5 AmpliPhi Biosciences Recent Development
    • 12.4 C3J Therapeutics
      • 12.4.1 C3J Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Phage Therapy Introduction
      • 12.4.4 C3J Therapeutics Revenue in Phage Therapy Business (2014-2019)
      • 12.4.5 C3J Therapeutics Recent Development
    • 12.5 Enbiotix
      • 12.5.1 Enbiotix Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Phage Therapy Introduction
      • 12.5.4 Enbiotix Revenue in Phage Therapy Business (2014-2019)
      • 12.5.5 Enbiotix Recent Development
    • 12.6 InnoPhage
      • 12.6.1 InnoPhage Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Phage Therapy Introduction
      • 12.6.4 InnoPhage Revenue in Phage Therapy Business (2014-2019)
      • 12.6.5 InnoPhage Recent Development
    • 12.7 iNtODEWorld
      • 12.7.1 iNtODEWorld Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Phage Therapy Introduction
      • 12.7.4 iNtODEWorld Revenue in Phage Therapy Business (2014-2019)
      • 12.7.5 iNtODEWorld Recent Development
    • 12.8 Intralytix
      • 12.8.1 Intralytix Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Phage Therapy Introduction
      • 12.8.4 Intralytix Revenue in Phage Therapy Business (2014-2019)
      • 12.8.5 Intralytix Recent Development
    • 12.9 Locus Biosciences
      • 12.9.1 Locus Biosciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Phage Therapy Introduction
      • 12.9.4 Locus Biosciences Revenue in Phage Therapy Business (2014-2019)
      • 12.9.5 Locus Biosciences Recent Development
    • 12.10 Phagomed
      • 12.10.1 Phagomed Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Phage Therapy Introduction
      • 12.10.4 Phagomed Revenue in Phage Therapy Business (2014-2019)
      • 12.10.5 Phagomed Recent Development
    • 12.11 Pherecydes Pharma
    • 12.12 TechnoPhage
    • 12.13 Eligo Bioscience
    • 12.14 Phagelux

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Phage therapy or viral phage therapy is the therapeutic use of bacteriophages to treat pathogenic bacterial infections.[1] Phage therapy has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
      In 2018, the global Phage Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Phage Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Phage Therapy development in United States, Europe and China.

      The key players covered in this study
      Phage International
      Adaptive Phage Therapeutics
      AmpliPhi Biosciences
      C3J Therapeutics
      Enbiotix
      InnoPhage
      iNtODEWorld
      Intralytix
      Locus Biosciences
      Phagomed
      Pherecydes Pharma
      TechnoPhage
      Eligo Bioscience
      Phagelux

      Market segment by Type, the product can be split into
      Oral
      External Application
      Surgical Treatment

      Market segment by Application, split into
      Human Medicine
      Veterinary Science
      Agriculture

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Phage Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Phage Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Phage Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now